BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $43,000 | +26.5% | 497 | +17.5% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | +9.7% | 423 | +10.7% | 0.00% | +50.0% |
| Q2 2021 | $31,000 | 0.0% | 382 | +5.2% | 0.00% | -33.3% |
| Q1 2021 | $31,000 | +10.7% | 363 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $28,000 | +21.7% | 349 | +22.9% | 0.00% | +50.0% |
| Q3 2020 | $23,000 | -23.3% | 284 | -22.6% | 0.00% | -50.0% |
| Q1 2020 | $30,000 | -90.4% | 367 | -90.1% | 0.00% | -87.5% |
| Q4 2019 | $311,000 | +1.6% | 3,708 | +6.3% | 0.03% | -3.0% |
| Q3 2019 | $306,000 | -1.3% | 3,489 | -7.6% | 0.03% | 0.0% |
| Q2 2019 | $310,000 | +3.7% | 3,776 | +2.9% | 0.03% | -56.6% |
| Q1 2019 | $299,000 | +1050.0% | 3,671 | +815.5% | 0.08% | +1420.0% |
| Q4 2018 | $26,000 | -44.7% | 401 | -34.3% | 0.01% | -77.3% |
| Q3 2018 | $47,000 | -53.0% | 610 | -61.5% | 0.02% | -21.4% |
| Q3 2017 | $100,000 | -99.9% | 1,585 | -24.0% | 0.03% | -9.7% |
| Q2 2017 | $126,000,000 | -20.3% | 2,085 | -26.5% | 0.03% | -29.5% |
| Q1 2017 | $158,000,000 | -36.8% | 2,835 | -49.7% | 0.04% | 0.0% |
| Q4 2016 | $250,000,000 | +94957.0% | 5,634 | +1.8% | 0.04% | -6.4% |
| Q3 2016 | $263,000 | +86.5% | 5,534 | +76.5% | 0.05% | +4.4% |
| Q2 2016 | $141,000 | -15.6% | 3,135 | -23.3% | 0.04% | -23.7% |
| Q1 2016 | $167,000 | -5.1% | 4,087 | -11.6% | 0.06% | -10.6% |
| Q4 2015 | $176,000 | +11.4% | 4,624 | -3.9% | 0.07% | +15.8% |
| Q3 2015 | $158,000 | -60.1% | 4,810 | -15.2% | 0.06% | -58.1% |
| Q2 2015 | $396,000 | -0.5% | 5,670 | -2.6% | 0.14% | +6.2% |
| Q1 2015 | $398,000 | -9.1% | 5,820 | -2.5% | 0.13% | -12.3% |
| Q4 2014 | $438,000 | -18.6% | 5,970 | -20.4% | 0.15% | +36.4% |
| Q3 2014 | $538,000 | -15.4% | 7,503 | -12.8% | 0.11% | -67.8% |
| Q2 2014 | $636,000 | – | 8,603 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |